Introduction
of antifungal action of CsA, FK506 and rapamycin in the yeast Saccharomyces cerevisiae are essentially identical Cryptococcus neoformans is an opportunistic pathogen that to the immunosuppressive effects in T-cell proliferation primarily afflicts immunocompromised patients. Infection (reviewed in Cardenas et al., 1994a) . CsA and FK506/ initiates in the lung following inhalation, spreads hematorapamycin diffuse into the cell and form complexes with genously to the brain, and results in meningoencephalitis the cyclophilin A and FKBP12 proteins, respectively. ( Kwon-Chung et al., 1992; Cox and Perfect, 1993; Mitchell The resulting cyclophilin A-CsA and FKBP12-FK506 and . Of serious concern is an increased complexes inhibit calcineurin (Liu et al., 1991) , a Ca 2ϩ / incidence of C.neoformans infections in AIDS patients calmodulin-activated serine/threonine-specific phosphatwho, following treatment, require lifelong suppressive ase required for stress responses or viability in yeast therapy to prevent relapse. Existing treatments (ampho- (Cyert et al., 1991; Cyert and Thorner, 1992 ; Nakamura tericin B and fluconazole) have toxic side effects, and druget al., 1993; Breuder et al., 1994; Cunningham and Fink, resistant strains are arising, necessitating identification of novel targets for therapeutic intervention. Several virulence 1994; Garrett-Engele et al., 1995; Hemenway et al., 1995; Tanida et al., 1995) , and for gene activation by the transcription factor NF-AT in T cells (Clipstone and Crabtree, 1992; O'Keefe et al., 1992; Jain et al., 1993; Northrop et al., 1994) . The targets of the FKBP12-rapamycin complex are the yeast TOR1 and TOR2 proteins and their mammalian homolog (RAFT1/FRAP/mTOR), novel kinase homologs required for cell cycle progression (Heitman et al., 1991a; Kunz et al., 1993; Brown et al., 1994; Helliwell et al., 1994; Sabatini et al., 1994; Sabers et al., 1995; Alarcon et al., 1996) . Because the mechanisms of CsA, FK506 and rapamycin action are conserved from yeast to man, similar target proteins may mediate their effects in other organisms.
Here we report that CsA, FK506 and rapamycin have potent antifungal activity against the opportunistic fungal pathogen C.neoformans. Remarkably, CsA and FK506 are not toxic to C.neoformans at 24°C in vitro, but are markedly toxic at 37°C. Analysis of drug-resistant C.neoformans mutants supports a model in which CsA and FK506 bound to cryptococcal homologs of cyclophilin A and FKBP12 inhibit a common target required for temperature-resistant growth. To test if this target is calcineurin, the C.neoformans gene encoding the calelevated temperature. C.neoformans wild-type strains JEC20 and JEC21, the isogenic FK506/rapamycin-resistant mutant strains C20F1, cineurin A catalytic subunit was cloned, sequenced and C20F2 and C21F3, and the FK506-resistant mutant strain C21F2 were disrupted. Calcineurin mutant strains were viable but grown at 22, 30 or 37°C on YPD medium, and on YPD medium exhibited temperature-, CO 2 -and pH-sensitive growth containing 1 μg/ml rapamycin, 0.1 μg/ml FK506 or 100 μg/ml CsA.
in vitro and were no longer pathogenic in a rabbit model of cryptococcal meningitis. These mutant phenotypes were complemented by re-introduction of the wild-type the target of CsA and FK506 antifungal activity and demonstrate that calcineurin is required for three distinct H99 CsA Ͼ100 μg/ml Ͼ100 μg/ml 1-5 μg/ml virulence traits of C.neoformans, possibly as a component (MATα) FK506 Ͼ100 μg/ml Ͼ100 μg/ml 5 ng/ml of a signal transduction cascade required for fungal pathorapa 1 μg/ml 1 μg/ml 1 μg/ml JEC20 CsA Ͼ100 μg/ml 0.5 μg/ml 0.1 μg/ml genesis.
(MATa) FK506 Ͼ1 μg/ml Ͻ0.1 μg/ml Ͻ0.1 ng/ml rapa 1 μg/ml 1 μg/ml 1 μg/ml JEC21 CsA Ͼ100 μg/ml 5 μg/ml 0.5 μg/ml
Results
(MATα) FK506 Ͼ1 μg/ml 1 μg/ml Ͻ0.1 ng/ml Cyclosporin A and FK506 are toxic to rapa 1 μg/ml 1 μg/ml 1 μg/ml
C.neoformans at elevated temperature by inhibition of a common target protein
We first tested whether CsA affects growth of several Taken together, these pharmacological findings suggest that calcineurin, the only known common target of CsA strains of C.neoformans in different liquid or solid media at different temperatures. Remarkably, we discovered that and FK506, might be required for C.neoformans growth at elevated temperature in vitro. CsA does not inhibit C.neoformans growth at lower temperatures but markedly inhibits growth at 37°C for all As a next step to determine the mechanism of action and targets of CsA and FK506, we took a genetic approach. strains tested (Figure 1) . Different liquid or solid media had little effect. These observations resolve earlier discrepant Spontaneous CsA-or FK506-resistant mutants were isolated in an isogenic pair of MATa and MATα C.neostudies on CsA action, which were performed at different growth temperatures (Perfect and Durack, 1985; Mody formans strains suitable for genetic analyses (strains JEC20 and JEC21, see Materials and methods). The majority of et al., 1988) . Our observations suggest that CsA inhibits a protein required for C.neoformans growth at elevated these mutants (596/600) were found to be resistant to both CsA and to FK506, but not to unrelated compounds temperature.
Because CsA could inhibit either calcineurin or a [5-fluoro-orotic acid (5-FOA), cycloheximide]. These findings are consistent with a common target protein, such cyclophilin required for growth at 37°C, we tested the effects of FK506, which also inhibits calcineurin but not as calcineurin, that is now resistant to both drugs or no longer essential at 37°C in the drug-resistant mutants. cyclophilins. As shown in Figure 1 , FK506 was also toxic to C.neoformans cells grown at 37°C but was not toxic
In this genetic screen, we also identified four unusual mutants that were resistant to FK506 but not to CsA to cells grown at 22°C. The effects of CsA and FK506 were quantified by determining the minimum inhibitory ( Figure 1 , Table II ). Three of these FK506-resistant mutants (C20F1, C20F2 and C21F3) were also resistant concentrations (MIC) for each drug at different temperatures, revealing that CsA and FK506 are 100-to 10 000-to rapamycin (Figure 1 ), a drug structurally related to FK506 that is also toxic when bound to FKBP12. This fold more toxic at 37°C compared with 22°C (Table I) . that co-migrated with PCR products using S.cerevisiae was recovered from a size-selected EcoRI genomic library. three mutations were partially complemented by heteroBoth strands of the ORF and 5Ј-and 3Ј-untranslated logous expression of yeast FKBP12 from the C.neoformans regions were sequenced. To confirm the sequence and actin promoter borne by the telomeric plasmid pCnTel1 exon-intron borders, several cDNA fragments were (data not shown; for details, see Materials and methods).
retrieved by PCR from a C.neoformans cDNA library and In S.cerevisiae, FKBP12 mutations are known to confer sequenced. Finally, the 5Ј end of the gene was determined a similar recessive FK506/rapamycin-resistant phenotype by RACE (see Materials and methods) using total RNA (Heitman et al., 1991a) . Taken together, our observations from strain H99 as template. suggest that a common FK506-binding protein, such as
The sequence of the C.neoformans calcineurin A gene FKBP12, mediates FK506 and rapamycin toxicity in CNA1 and its predicted protein product are depicted in C.neoformans. Figure 2 . The CNA1 ORF is punctuated by multiple small One mutant (C21F2) was resistant to FK506 but not to introns with consensus donor, acceptor and branch splice rapamycin. In this mutant, drug resistance was conferred sites (underlined in Figure 2 ). As shown in Figure 3 , by a mutation that was dominant by heterokaryon analysis the predicted C.neoformans CNA1 gene product exhibits and segregated independently of the recessive FK506/ marked sequence identity with the calcineurin A proteins rapamycin-resistant mutations in genetic crosses (data from other organisms, especially with calcineurin A from not shown). By analogy with calcineurin mutations in A.nidulans (70% identity) and N.crassa (73% identity).
S.cerevisiae that confer dominant FK506 resistance
The overall order of the protein domains is conserved, , this mutation might alter C.neoincluding the catalytic region, the calcineurin B-binding formans calcineurin to prevent inhibition by FKBP12-domain, the calmodulin-binding domain and the autoinhibitory domain (underlined in Figure 3 ). FK506. In summary, these pharmacological and genetic
The predicted product of the C.neoformans calcineurin studies support a model in which FKBP12-FK506 and A gene differs in that the protein is longer than other cyclophilin A-CsA complexes block C.neoformans growth calcineurins at the C-terminus and contains a longer at 37°C by inhibiting a common target, which we propose N-terminal end of similar length to and limited identity is calcineurin.
with the CMP1 calcineurin A subunit of S.cerevisiae. Figure 3) . Four degenerate pools shown), as is also the case in A.nidulans and N.crassa. of oligonucleotides corresponding to highly conserved peptides in this region were synthesized and used as Disruption of the C.neoformans calcineurin A gene primers in low stringency PCR reactions with a C.neoby homologous recombination formans cDNA library as template. All three possible
To determine the phenotype of C.neoformans mutants lacking calcineurin, the calcineurin A CNA1 gene was primer pairs yielded fragments of the predicted size The DNA sequence of the C.neoformans genomic locus encoding the calcineurin A catalytic subunit CNA1 is depicted and was determined from the genomic clone, multiple cDNA clones and a 5Ј-RACE product, as described in Materials and methods. The 5Ј-and 3Ј-untranslated regions and intronic sequences are in lower case and introns are numbered in order of occurrence from 5Ј to 3Ј. Exons of the CNA1 open reading frame are in upper case with the translated protein sequence below the DNA sequence in upper case single letter amino acid abbreviations. The approximate 5Ј mRNA start site determined by RACE, consensus splice donor (GTNNGY), branch (CTRAY) and acceptor (YAG) sites, and two in-frame stop codons at the end of the ORF are underlined.
disrupted by replacing a large fragment of the gene with First, we used the CNA1 genomic locus from the same strain used for transformation to decrease inhibition of the ADE2 selectable marker to result in the calcineurin null mutation cna1Δ::ADE2 ( Figure 4A ). We took two homologous recombination by mismatch repair. Second, we used the ADE2 gene from a divergent serotype D measures to decrease non-homologous recombination. .nidulans, N.crassa, humans and S.cerevisiae (yeast CMP1 protein) . Identical amino acids are indicated by dashes. Non-identical amino acids are in lower case. In some cases, gaps were introduced to maximize alignment and are indicated by periods. Amino acid numbers are to the right. The highly conserved calcineurin B-binding, calmodulinbinding and autoinhibitory domains are underlined. A small non-homologous insert in the human protein is indicated by an X, and its sequence is depicted at the bottom.
strain to reduce gene conversion at the ade2 locus.
H99. Because homologous recombination occurs at low frequency in C.neoformans, adenine prototrophic trans-DNA was introduced by biolistic transformation into the C.neoformans serotype A strain M049, an isogenic nonformants were first selected at 24°C and then screened for the phenotype we predicted would result from calcineurin reverting ade2 mutant of the pathogenic serotype A strain mutation, namely temperature-sensitive growth. RemarkTo confirm that the calcineurin A gene mutation abrogates calcineurin expression, proteins from isogenic C.neoably, 16 of 200 ADE ϩ transformants with cna1Δ::ADE2 (8%) were viable at 24°C but failed to grow at 39°C formans CNA1 wild-type and cna1Δ deletion strains were fractionated by SDS-PAGE, transferred to nitrocellulose in vitro. This finding provides further support that CNA1 is the only gene encoding calcineurin A in C.neoformans. and analyzed by [ 125 I]calmodulin overlay ( Figure 4C ). Extracts from S.cerevisiae strains expressing or lacking the PCR analyses of genomic DNA from the isogenic wildtype and candidate disruption strains (both with and two yeast calcineurin A catalytic subunits were analyzed in parallel, revealing a doublet of 64 and 66 kDa calmodulinwithout the temperature-sensitive phenotype) revealed that the CNA1 calcineurin A gene had been replaced with the binding proteins corresponding to the known yeast calcineurin A CMP1 and CMP2 subunits, respectively ( Figure  cna1Δ ::ADE2 deletion mutation in temperature-sensitive transformants but not in temperature-resistant trans-4C). Extracts from the C.neoformans CNA1 wild-type strain H99 contained an abundant calmodulin-binding formants, and that all transformants with the cna1Δ allele exhibited a temperature-sensitive phenotype ( Figure 4B protein of~80 kDa that was absent in extracts from the isogenic cna1Δ mutant strain ( Figure 4C ). These findings and data not shown). Similar findings were obtained with a second cna1::ADE2 disruption allele in which the ADE2 confirm that the C.neoformans calcineurin A gene has indeed been disrupted and that the size of the CNA1 gene was inserted between two XhoI sites in the CNA1 gene (data not shown). These findings support the concluprotein is in good agreement with that predicted from the CNA1 gene sequence. In addition, we conclude that the sion that the cna1 mutation alone confers a temperaturesensitive phenotype.
CNA1 protein: (i) is the only calcineurin A catalytic CO 2 -and pH-sensitive growth. The wild-type C.neoformans strain suppressor mutations (Sup8, Sup24) (lanes 3 and 4) or the transformed H99 (wild-type H99, A and C), the isogenic calcineurin A deletion wild-type CNA1 gene (lane 5), amplified by PCR with flanking mutant strain cna1Δ::ADE2 (cna1Δ, B and D) and the calcineurin primers and analyzed on a 1% agarose gel. The products from wildcna1Δ mutant strain transformed with the wild-type CNA1 gene type CNA1 gene and from the cna1Δ::ADE2 disruption are indicated (cna1Δ ϩ CNA1, data not shown) were grown in triplicate in liquid by the arrowhead and arrow, respectively, to the left. Molecular weight RPMI medium at 30°C for 0-72 h in an atmosphere of air at pH 7.0 size standards are indicated in kb (lane 6). (C) Isogenic calcineurin A (d), air at pH 7.3 (m) or 5% CO 2 at pH 7.0 (s) and the number of wild-type (CNA1), calcineurin A mutant (cna1Δ) and the calcineurin surviving colony-forming units (CFU) measured by dilution and A mutant strains containing the sup8 suppressor mutation (cna1Δ ϩ plating on YPD medium and averaged for the triplicate cultures. SUP8) or the wild-type calcineurin A gene (cna1Δ ϩ CNA1) were grown for 4 days on YPD medium at 30, 37 and 39°C without or with 1 μg/ml FK506.
original cna1Δ mutation and an ectopic copy of the CNA1 calcineurin A gene were now present ( Figure 5B ). Thus, the growth defect conferred by the cna1 mutation is subunit in C.neoformans, (ii) represents a major calmodulin-binding protein in C.neoformans and (iii) is expressed recessive and is complemented by the wild-type CNA1 gene. In contrast, we have isolated a number of suppressor at both 24 and 37°C ( Figure 4C ).
mutations that can restore growth of the cna1Δ mutant strain at 37°C but not at 39°C ( Figure 5C ). PCR analysis Growth of C.neoformans mutants lacking calcineurin is temperature sensitive in vitro indicates that these strains contain only the original cna1Δ mutation ( Figure 5B ). In these cases, growth at 37°C Given the temperature sensitivity of CsA and FK506 effects, we have investigated the consequences of loss of is resistant to FK506, indicating that these suppressor mutations partially bypass the requirement for calcineurin calcineurin function on growth at low and high temperatures. As shown in Figure 5 , growth of the isogenic CNA1 for growth at elevated temperature. Further analysis of these suppressor mutations should permit the identification wild-type and the cna1Δ calcineurin mutant strains was indistinguishable at 24°C. In contrast, the calcineurin of downstream elements of the calcineurin signaling cascade in C.neoformans. Taken together, our findings mutant strain was severely growth impaired at 37°C and inviable at 39°C (Figure 5A ). At intermediate conditions indicate that calcineurin plays a central role in growth at elevated temperature in vitro. (37°C), growth of the cna1Δ mutant strain was not inhibited further by either FK506 or CsA, indicating that FK506 and CsA are not toxic in cells lacking calcineurin.
C.neoformans calcineurin mutants are CO 2 and pH sensitive and exhibit altered responses to cations In addition, the extent of growth inhibition conferred by calcineurin deletion was equivalent to that imposed by To infect mammalian hosts, C.neoformans must survive not only at elevated temperature, but also in the increased CsA or FK506 in the calcineurin wild-type strain at all temperatures, further indicating that calcineurin encoded levels of CO 2 and the physiological alkaline pH present in host tissues. Remarkably, we find that 5% CO 2 profoundly by the CNA1 gene is the sole target of FK506 and CsA in C.neoformans.
inhibits the growth of the cna1Δ calcineurin mutant strains in liquid RPMI medium in vitro ( Figure 6D ). In contrast, When the CNA1 gene encoding wild-type calcineurin A was re-introduced into the cna1Δ mutant strain, growth the isogenic calcineurin wild-type strain proliferates normally in the presence of CO 2 and both strains proliferate at both 37 and 39°C was restored and this growth was sensitive to FK506 ( Figure 5C ). PCR analyses of genomic normally in air (~0.04% CO 2 ) ( Figure 6C and D) . Similarly, the cna1Δ calcineurin mutant strains were unable to DNA from these transformants confirmed that both the proliferate in RPMI medium at pH 7.3 ( Figure 6B ), whereas both calcineurin wild-type and cna1Δ calcineurin mutant strains proliferated normally in RPMI at pH 7.0 in vitro ( Figure 6A and B) . Transformation of the calcineurin mutant strain with the wild-type CNA1 calcineurin A gene restored growth in either the presence of CO 2 or at pH 7.3 (data not shown), confirming that both the CO 2 -and the pH-sensitive growth defects are attributable to loss of calcineurin function. These findings link calcineurin to the ability of C.neoformans to survive three distinct environmental conditions required for host infection and pathogenesis, suggesting that calcineurin may coordinate the regulation of virulence traits in this organism.
In S.cerevisiae, calcineurin is required for resistance to the toxic effects of either Li ϩ or Mn 2ϩ cations. C.neoformans mutants lacking calcineurin, or wild-type cells exposed to CsA or FK506, are also sensitive to 50 mM whereas the isogenic calcineurin wild-type strain was (d, wild-type H99) , the isogenic calcineurin A cna1Δ mutant strain (j, cna1Δ) or the isogenic cna1Δ mutant strain into which the wildMn 2ϩ sensitive (data not shown), precisely the opposite type CNA1 gene had been re-introduced (m, cna1Δ ϩCNA1). CSF of the phenotype conferred by calcineurin mutations in was removed on days 2, 5, 7 and 12 following inoculation, and the S.cerevisiae. Both mutant phenotypes were complemented number of surviving organisms (expressed as the mean of log 10 CFU/ when the cna1Δ mutant strain was transformed with ml CSF from three rabbits at each time point, CFU colony-forming the wild-type calcineurin A gene (not shown). These units) determined by serial dilution and plating on YPD medium with growth at 24°C for 4 days. Counts were significantly lower in the observations indicate that calcineurin plays a general role cna1Δ strain compared with wild-type H99 at all time points (P Ͻ0.01 in regulating cation homeostasis in microorganisms.
by T-test for unpaired means) and the cna1Δ ϩ CNA1 counts were only lower than wild-type on day 12 (P Ͻ0.03).
C.neoformans mutants lacking calcineurin A are not pathogenic
Our findings suggested that calcineurin might be required to normal rabbit body temperature and emphasizes the importance of yeast growth rate for virulence. In summary, for virulence of C.neoformans, which requires survival in mammalian hosts, whose body temperatures are equal to our findings reveal that calcineurin is required for growth in vivo in a mammalian host at a clinically relevant site or exceed 37°C and in which alkaline pH and CO 2 at high levels are present. To test this hypothesis, we employed of infection. an animal model of cryptococcal meningitis in which rabbits are immunosuppressed with steroids and inoculated
Discussion
intrathecally with wild-type or mutant C.neoformans strains. Survival of C.neoformans in the CNS was deterOur findings reveal that the immunosuppressive antifungal natural products CsA, FK506 and rapamycin are toxic to mined by removal of cerebral spinal fluid (CSF) and quantification of colony-forming units by serial dilution the opportunistic fungal pathogen C.neoformans. Interestingly, CsA and FK506 toxicity was only manifested and plating. Previous studies have established the value of this model system in studies of C.neoformans virulence under conditions of elevated growth temperature. This observation, and additional genetic evidence, suggested and the action of antifungal agents (Perfect et al., 1980 (Perfect et al., , 1983 Perfect and Durack, 1985; Lodge et al., 1994) . that the only known common target of CsA and FK506 in other organisms, the Ca 2ϩ /calmodulin-dependent protein As shown in Figure 7 , whereas wild-type C.neoformans strain H99 persists for up to 12 days in the CSF of phosphatase calcineurin, might be required for growth of C.neoformans at 37°C but not at 24°C in vitro. Because immunosuppressed animals, the isogenic cna1Δ calcineurin mutant strain was cleared rapidly from the pathogenesis requires survival at the body temperature of the infected mammalian host, this further suggested that immunosuppressed hosts. By days 2 and 5 following inoculation, survival of the calcineurin mutant strain was calcineurin might be required for pathogenesis of C.neoformans in vivo. reduced~400-and~10 000-fold respectively compared with the isogenic wild-type strain, as measured by quantitHere we describe the isolation of the CNA1 gene encoding the calcineurin A catalytic subunit of C.neoative colony counts (Figure 7 ). In comparison, virulence was largely restored in the cna1Δ strain by re-introduction formans. Disruption of the calcineurin A CNA1 gene abrogates calcineurin expression, confers temperature-, of the wild-type calcineurin A gene. Virulence was not restored to the wild-type level at the latest time point, CO 2 -and pH-sensitive conditional growth in vitro, and prevents pathogenicity in vivo in an animal model of which we attribute to the fact that while the introduced ectopic calcineurin A wild-type gene fully restored growth cryptococcal meningitis. Re-introduction of the wild-type calcineurin A gene complemented these growth defects to the wild-type level on solid YPD medium at 39 and at 37°C in liquid medium, it did not fully restore growth at and largely restored virulence. Thus, calcineurin is required for the opportunistic fungal pathogen C.neoformans to 39°C in liquid RPMI medium. This temperature is similar and other models, and to identify downstream effectors of calcineurin, would be to characterize suppressor mutations that restore growth to calcineurin mutants at 37°C. In summary, our studies reveal that calcineurin is required for virulence and may delineate the first elements of a signal transduction cascade required for fungal pathogenesis.
By analogy with other systems, the targets of calcineurin might include ion pumps or transcription factors, which could regulate expression of other proteins required for virulence. The role of calcineurin in CO 2 -and pH-resistant growth is intriguing given the known role of calcineurin in ion, pH and Ca 2ϩ homeostatic mechanisms in other organisms such as S.cerevisiae (Nakamura et al., 1993; Fink, 1994, 1996; 1995; Tanida et al., 1995) . Little is known about how virulence. This figure outlines our hypotheses concerning the mechanisms of action of CsA, FK506 and rapamycin (Rapa) and the CO 2 affects C.neoformans growth beyond that it potently roles of the target proteins, cyclophilin A, calcineurin A and B, induces capsule formation in vivo (Granger et al., 1985 membrane or vacuolar H ϩ -ATPase (Mendoza et al., 1994; Garrett-Engele et al., 1995; Hemenway et al., 1995; Tanida et al., 1995) . Calcineurin is required for resistance to Li ϩ grow at elevated temperature, in the presence of CO 2 and cations in both yeast and C.neoformans, possibly via at physiological pH in vitro and for survival and virulence regulation of conserved proteins, such as homologs of the in an infected mammalian host.
yeast Na ϩ /Li ϩ pump PMR2A. In contrast, calcineurin We summarize our findings in the model in Figure 8 .
mutations confer Mn 2ϩ sensitivity in S.cerevisiae but Mn 2ϩ Our pharmacological and genetic findings support the tolerance in C.neoformans, suggesting that calcineurin may hypothesis that in C.neoformans, as in other systems, differentially regulate homologs of the yeast Mn 2ϩ and CsA, FK506 and rapamycin diffuse into the cell, bind Ca 2ϩ pumps PMR1, VCX1/HUM1 and PMC1 in C.neocyclophilin A and FKBP12, and form protein-drug comformans (Cunningham and Fink, 1996; Pozos et al., 1996) . plexes that inhibit components of signal transduction Our findings also suggest that inhibitors of calcineurin, cascades. Our findings indicate that calcineurin is the or of other elements of this cascade, might be therapeuticcommon and universal target of cyclophilin A-CsA and ally useful. However, CsA exacerbates cryptococcal FKBP12-FK506. Based on the known roles of calcineurin meningitis in the rabbit model system (Perfect and Durack, in mediating calcium-activated signal transduction in T 1985) , most likely as the consequence of immunosupprescells and in yeast, an attractive hypothesis is that calsion and because CsA does not cross the blood-brain cineurin is activated by an increase in intracellular calcium barrier. Although FK506 does penetrate the CNS, FK506 and calmodulin in response to an unknown extracellular also exacerbates C.neoformans meningitis in rabbits, most signal present in the infected host. Activated calcineurin likely as a result of immunosuppression (Odom et al. , would then in turn dephosphorylate specific proteins 1997). Thus, potent immunosuppression by the presently required for survival at elevated temperature, growth in available agents outweighs any beneficial antifungal effect. the presence of CO 2 and at alkaline pH, and pathogenesis.
Non-immunosuppressive CsA and FK506 analogs have In this model, other elements that might be required been described. One FK506 analog, L-685,818, is known for virulence include calmodulin, increased intracellular potently to inhibit bovine calcineurin when bound to calcium and the machinery that provides it, and one or S.cerevisiae FKBP12 but not when bound to human more specific calcineurin substrates. The finding that FKBP12 (Rotonda et al., 1993) . As a result, L-685,818 is calcineurin is required under three distinct conditions not immunosuppressive and is a potent antagonist of present in the infected host suggests that calcineurin may FK506 actions in vitro and in vivo (Dumont et al., be a central regulator of virulence in C.neoformans. 1992). We find that L-685,818 is toxic to C.neoformans. A less likely alternative hypothesis is that calcineurin L-685,818 is, like FK506, toxic at 37°C but not at is not part of a signal transduction pathway required for 24°C, and FK506-resistant mutants are cross-resistant to virulence, but is instead required to maintain activity of L-685,818, indicating a conserved mechanism of action components required for growth at high temperature and (Odom et al., 1997) . Our findings establish that this non-CO 2 and pH resistance. Such a model would require that immunosuppressive analog takes advantage of structural some proteins differ in phosphorylation state at 37 and differences between host and fungal FKBP12 and cal-24°C, or that activity at 37°C requires dephosphorylation whereas activity at 24°C does not. One means to test these cineurin and, as a result, spares host immune function yet inhibits fungal growth. Further studies of this and other the virulent yeast is induced by shift from 25 to 37°C and is associated with a heat shock response (Lambowitz analogs are warranted.
Our studies are the first to implicate calcineurin in the et Maresca et al., 1994) . Moreover, the relative pathogenicity of H.capsulatum isolates is correlated with virulence of a human pathogen. Calcineurin previously has been identified in a number of other microorganisms.
ability to grow at elevated temperatures (Medoff et al., 1986) . Thus, temperature-resistant growth is linked to For example, in S.cerevisiae calcineurin is required for survival during cation stress (Nakamura et al., 1993;  pathogenesis. The association of temperature-resistant growth and Breuder et al., 1994) , recovery from pheromone arrest (Cyert et al., 1991; Cyert and Thorner, 1992 ) and for virulence is not limited to pathogenic fungi and yeasts. The heat shock response is thought to be involved in viability of some mutant strains (Parent et al., 1993; Breuder et al., 1994; Garrett-Engele et al., 1995;  pathogenesis and differentiation of parasites, such as Trypanosoma brucei and Leishmania major, the causative Hemenway et al., 1995; Tanida et al., 1995) . Calcineurin is also inappropriately activated and toxic in mutant yeast agents of African sleeping sickness and zoonotic cutaneous leishmaniasis, respectively (Van Der Ploeg et al., 1985) . strains with altered Ca 2ϩ homeostasis Fink, 1994, 1996) . In S.pombe, calcineurin is induced by Following transmission from the insect vectors at 25°C, these parasites adapt to and survive in mammalian hosts nitrogen starvation and is required for growth at low temperature, mating and proper cytokinesis (Yoshida et al., at 37°C or higher. Similarly, virulence of pathogenic bacteria has been associated with temperature (reviewed 1994; Plochocka-Zulinska et al., 1995) . In A.nidulans, calcineurin is essential and regulates cell cycle progression in Maurelli, 1989) . Invasion of mammalian cells by the Gram-negative bacterium Shigella is blocked by growth (Rasmussen et al., 1994) . Thus, calcineurin plays diverse roles in different microorganisms. Our studies reveal that at 30°C and is restored by growth at 37°C (Maurelli et al., 1984) . A number of Shigella virulence genes have been the mechanisms of action of CsA and FK506 are highly conserved from yeast to pathogenic fungi to man. Other identified that are transcriptionally induced at 37°C compared with 30°C. These genes are controlled by the virR yeasts and pathogenic fungi whose growth is known to be inhibited by CsA or FK506, including Coccidioides repressor which, when mutated, results in loss of invasion (Maurelli and Sansonetti, 1988) . Virulence of enteroimmitis (Kirkland and Fierer, 1983) , Aspergillus fumigatus (Hatanaka et al., 1988) , N.crassa (Tropschug et al., 1989) invasive Escherichia coli, which causes dysentery, and Yersinia species are similarly temperature regulated (Bolin and Aspergillus niger (Kirkland and Fierer, 1983) , are likely to be sensitive to both drugs via inhibition of and Wolf-Watz, 1988; Isberg et al., 1988; Small and Falkow, 1988) . calcineurin. If so, the spectrum of calcineurin inhibitors might include many pathogenic yeast and fungi.
Our studies define a novel function for calcineurin in pathogenesis of the opportunistic fungal pathogen An important technical advance of our studies was the high rate of homologous recombination. In previous C.neoformans. Genetic, biochemical and structural information available for calcineurin, and clinical experistudies, the CAP59 gene was disrupted at a frequency of 1 in 10 000 (Chang and Kwon-Chung, 1994) . By comence in the use of calcineurin inhibitors and analogs can now be brought to bear on signal transduction cascades parison, the N-myristoyl transferase (NMT) gene was disrupted at a frequency of~3% (Lodge et al., 1994) . As regulating fungal pathogenesis as targets for novel antifungal agents. in that study, we employed a genomic clone isolated from the strain used for transformation to avoid mismatches during homologous recombination. To limit gene conver-
Materials and methods
sion at ade2, we used an ADE2 gene from a serotype D Strains, media and compounds strain that is polymorphic with the recipient serotype A The S.cerevisiae strains employed here were as described (Cardenas ade2 gene. Our findings indicate that it is now feasible to et al., 1994b) . Most C.neoformans strains were isogenic derivatives of disrupt any non-essential gene in this pathogenic organism. the serotype A strain H99 or of the isogenic pair of MATa and MATα Previous observations have linked fungal pathogenicity serotype D strains JEC20 and JEC21 (Moore and Edman, 1993) . In addition, drug sensitivity was assessed for the serotype A strain 145A to CO 2 -and temperature-regulated physiology. In C.neo- (Mody et al., 1988) . The C.neoformans strains were routinely grown formans, polysaccharide capsule is induced by CO 2 , and using rich (YPD) and synthetic medium as for S.cerevisiae as described mutants that lack a capsule or do not induce capsule in (Sherman, 1991) , and immunosuppressant-containing medium was preresponse to CO 2 are avirulent (Granger et al., 1985 ; Kwonpared as described (Heitman et al., 1993) . V8 mating-starvation medium Chung and Rhodes, 1986) . A C.neoformans strain with a contained 5% V8 vegetable juice (Campbells Soup Co.), 0.5 g/l KH 2 PO 4 , and 4% agar and was adjusted to pH 7.2 with KOH prior to autoclaving. temperature-sensitive mutation in an unidentified gene Regeneration medium for biolistic transformations was as described was avirulent in mice (Kwon-Chung et al., 1982) . In the . 5-FOA medium to select ura5 auxotrophic pathogenic yeast Candida, virulent C.albicans strains grow C.neoformans mutants and plasmid loss experiments was as described at 42°C whereas closely related but avirulent C.stellatoidea (Kwon-Chung et al., 1992) . Where indicated, 10 μg/ml cycloheximide was added for 5-FOA plus cycloheximide media. Canavanine-and strains do not (Kamiyama et al., 1989) . Similarly, some cycloheximide-resistant C.neoformans mutants were selected as S.cerevisiae strains isolated from immunocompromised described for S.cerevisiae (Sikorski and Hieter, 1989) . FK506 was from human patients can grow at 42°C in vitro whereas many Fujisawa, L-685,818 from Merck and rapamycin from the NCI. laboratory strains do not (McCusker et al., 1994a) . The Isolation and genetic and biochemical analyses of ability of S.cerevisiae to grow at elevated temperature has drug-resistant mutants also been correlated with enhanced survival following Spontaneous independent mutants resistant to 100 μg/ml CsA or 1 μg/ml intravenous inoculation in mice (McCusker et al., 1994b) .
FK506 in YPD at 37°C were isolated in strain H99 and in the isogenic Finally, in the fungal pathogen Histoplasma capsulatum, strain pair JEC20 and JEC21 and tested for resistance to CsA, FK506 and rapamycin (1 μg/ml). a morphological transition from the avirulent mycelial to
We devised methods to select meiotic recombinants to analyze TRAAIACRTCCATRAA). PCR reactions were performed under conditions of low annealing stringency using primer pairs 292-294, 293-295 segregation of other unlinked markers of interest in the cross. We first isolated derivatives of strains JEC20, JEC21, C20F1, C20F2, C21F2
and 292-295 with a pooled C.neoformans cDNA library from strain B3501 (Stratagene) and S.cerevisiae genomic DNA from strain JK9-and C21F3 that were resistant to 5-FOA, 10 μg/ml cycloheximide or 60 μg/ml canavanine. In other organisms, recessive mutations confer 3da. PCR reaction conditions were 5 min at 94°C, 70 cycles of 30 s at 94°C, 30 s at 30°C and 90 s at 72°C, and a final 5 min 72°C step. PCR resistance to these agents. ura5 mutations were known to confer 5-FOA resistance in C.neoformans serotype D strains (Kwon-Chung et al., products of the expected sizes (160 bp for 292-294, 80 bp for 293-295 and 210 bp for 292-295) that co-migrated were obtained from 1992). Strains of opposite mating type and resistant to different drugs were co-cultured on V8 starvation-mating medium for 7-14 days at C.neoformans cDNA and S.cerevisiae genomic DNA and cloned with the TA system (Invitrogen) and sequenced, revealing a unique C.neoformans room temperature. Hyphae were removed, germinated on YPD medium and replica-plated to 5-FOA plus cycloheximide, 5-FOA plus canavanine sequence with identity to other calcineurin A proteins. Two primers with perfect homology (underlined) to the internal or canavanine plus cycloheximide media. The most suitable combination proved to be 5-FOA plus cycloheximide. By this means, random 5-FOAsequence, 329 (5Ј-CCATCGATAGATCTCGGAAAACTAAGACCACT-GGC) and 330 (5Ј-CCGGGTACCCTCGAGGTTAGGCAGCCAATAAand cycloheximide-resistant meiotic recombinants were obtained, and the segregation pattern of FK506 resistance mutations crossed to wild-GGATGGGG), were used to amplify a portion of the C.neoformans calcineurin A gene. This PCR product was gel purified, random primer type or to each other was ascertained. One other recombinant selection was employed in some cases in which 5-FOA-resistant URA ϩ LYS ϩ labeled and used as a probe to isolate the corresponding genomic locus from a C.neoformans strain H99 genomic library cloned as partial mutant strains were crossed to ura5 (5-FOA r ) lys1 or lys2 mutant strains (JEC157, JEC168 or JEC169) and ura5 LYS ϩ meiotic recombinants BamHI-Sau3A fragments in the λ vector EMBL3. A screen of~80 000 plaques yielded one strongly hybridizing clone. λ DNA was prepared selected on 5-FOA medium lacking lysine. In both cases, unselected auxotrophic markers, mating type and drug resistance mutations segregwith a Qiagen λ DNA prep kit, and an internal 3.5 kb BamHI fragment that bore the desired target sequence (based on PCR amplification with ated in an approximate ratio of 1:1.
To determine if mutations conferred dominant or recessive drug primers 329-330) was subcloned into the BamHI site in pUC18. The sequence of the insert was determined using appropriate subcloned resistance, we developed a method to isolate and analyze heterokaryons derived from a genetic cross. ura5 derivatives of FK506-resistant mutant fragments and synthetic primers. The original clone was incomplete and chimeric at a Sau3A site, and the intact gene was obtained by colony strains were crossed to the isogenic ade2 lys2 strains JEC170 (MATα) or JEC171 (MATa) on V8 mating medium and incubated for 7-14 days hybridization from a size-selected EcoRI library of H99 genomic DNA cloned in plasmid pUC18. The DNA sequence depicted in Figure 2 was at room temperature. Hyphae were removed and cultured on synthetic dextrose medium lacking uracil, adenine and lysine. Colonies with the completed from this intact 6.9 kb clone. In addition, a number of partial cDNA clones were retrieved from the C.neoformans cDNA library using odd ruffled morphology characteristic of heterokaryons (Whelan and Kwon-Chung, 1986) were streak purified and confirmed to be selfprimers designed against the genomic exonic sequences. DNA sequence analysis confirmed the predicted intron-exon borders and revealed a filamenting on V8 medium, a second independent feature of MATα/ MATa heterokaryons. In parallel, the isolated heterokaryons were tested number of DNA polymorphisms between the genomic CNA1 locus from serotype A strain H99 and cDNA clones from serotype D strain B3501, for growth on YPD medium containing 1 μg/ml FK506. as previously observed for other genes.
Heterologous expression of yeast FKBP12
The S.cerevisiae gene encoding FKBP12 (Heitman et al., 1991b) was 5Ј-RACE analysis Total RNA was prepared from C.neoformans strain H99 grown in YPD fused to the C.neoformans actin gene promoter (Cox et al., 1995) by PCR overlap (Horton et al., 1989) as follows. The yeast FKBP12 gene medium at 30°C. RACE was performed using the Marathon cDNA amplification kit (Clontech). First strand synthesis was with the CNA1-was PCR amplified with oligonucleotides 389 (5Ј-ACTCGCCCA-ACATGTCTATGTCTGAAGTAATTGAAGGTAA) and 48 (5Ј-CGCGspecific primer 363 (5Ј-AAGATGGTCATGACGGAGGGG). Following second strand synthesis and ligation to the Marathon cDNA adapter, a GGATCCGAATTCAAAATAATCACTGCTCATATATAG) to provide 5Ј overlap with the actin promoter sequence, and the actin promoter gene nested PCR was performed using an internal CNA1-specific primer (392: 5Ј-GTATCTGCCGGATTCCCACCG) and the adapter primer 1 (AP1) sequence was amplified with primers 387 (5Ј-GAATTCCCTGGAAGCG-AGTTG) and 418 (5Ј-GTTACCTTGAATTACTTCAGACATAGACATand a PCR program of 3 min at 94°C, 35 cycles of 30 s at 94°C, 30 s at 55°C, 2 min at 72°C, and a final 5 min at 72°C step. The GTTGGGCGAGTT). The~600 bp and~900 bp first round PCR products were gel purified, combined and PCR amplified with the flanking primers resulting PCR product was cloned in the TA cloning kit (Invitrogen) and sequenced. 387 and 48. The resulting second round~1500 bp PCR product was cloned in the TA system (Invitrogen), released with EcoRI and cloned in the EcoRI site of the C.neoformans URA5 telomeric plasmid pCnTel1
Disruption of the calcineurin A CNA1 gene A deletion mutation in the CNA1 calcineurin A gene was constructed (Edman, 1992) , to yield plasmid pAOT1 with the yeast FKBP12 gene expressed by the C.neoformans actin promoter.
by inserting a 2400 bp XhoI ADE2 fragment (blunted with Klenow and dNTPs) between two EcoRV sites in the CNA1 gene in the 3.5 kb BamHI The control plasmid pCnTel1 and the yFKBP12 expression plasmid pAOT1 were linearized with the rare-cutting Meganuclease I-SceI genomic fragment cloned in pUC18, yielding plasmid pcna1Δ::ADE2. Approximately 5 μg of supercoiled disruption plasmid DNA was purified (Omega-Nuclease, Boehringer) to reveal the linear telomeric ends of the vector. Linear DNA was introduced by electroporation-mediated on a Qiagen column, absorbed onto the surface of gold microprojectiles and introduced by biolistic transformation into strain M049, an Δade2 transformation (Edman, 1992) into ura5 mutant derivatives of strains JEC20, C20F1, C20F2 and C21F3. Ura ϩ transformants were selected isogenic derivative of strain H99. Adenine prototrophic transformants were selected on synthetic regeneration medium (1 M sorbitol) lacking and tested for growth on synthetic medium lacking uracil and containing 1 or 10 μg/ml FK506 or 1 μg/ml rapamycin. Yeast FKBP12 compleadenine at 24°C, streak purified and tested for growth at 24, 37 and 39°C on YPD medium. mented and restored rapamycin sensitivity in the C20F1, C21F2 and C21F3 mutants. Rapamycin resistance was restored in isolates that had Genomic DNA for PCR analyses was prepared as follows. Strains were grown as dense patches on YPD medium, resuspended in 500 μl lost the URA5 plasmid following passage on YPD medium and selection on 5-FOA. Yeast FKBP12 did not restore FK506 sensitivity, either of buffer (50 mM Tris-HCl pH 7.5, 20 mM EDTA, pH 7.5, 1% SDS), broken with 0.5 g of glass beads agitated for 3-5 cycles (1 min vortex, because the yeast FKBP12-FK506 complex does not inhibit C.neoformans calcineurin or because the level of yeast FKBP12 expressed is 1 min on ice) with a bead beater, and heated at 70°C for 10 min. Then 200 μl of 3 M KAc and 150 μl of 5 M NaCl were added, incubated for not sufficient to inhibit all available calcineurin. 20 min on ice and microcentrifuged. Nucleic acids were recovered from the resulting supernatants by addition of a one-third volume of 30% Isolation and characterization of the C.neoformans gene encoding calcineurin A PEG 3000 in 1.5 M NaCl and microcentrifugation for 5 min at 4°C. Pellets were resuspended in 100 μl of TE, treated for 5 min at 37°C Calcineurin A sequences from several organisms (Figure 3 ) were aligned and pools of oligonucleotides corresponding to highly conserved peptides with 8 ng of RNase, twice extracted with phenol:chloroform (1:1) and once with chloroform. DNA was ethanol precipitated, dried and were synthesized. Forward primers were 292 (HEAQDAGYRMY peptide; 5Ј-CAYGARGCICARGAYGCIGGITAYA/CGIATGTA) and 293 resuspended in 50 μl of TE. Genomic DNA prepared from wild-type, temperature-sensitive (ts) (NVMNIRQF peptide; 5Ј-AAYGTIATGAAYATIC/AGICARTT) and reverse primers were 294 (NVMNIRQF peptide; 5Ј-AAYTGICG/ and temperature-resistant C.neoformans strains was analyzed by PCR to determine whether the CNA1 gene had been disrupted. PCR reactions TIATRTTCATIACRTT) and 295 (FMDVFTW peptide; 5Ј-CCAIG-contained~0.05 μg of genomic DNA (0.05 μl of standard genomic daily for 12-14 days. Twenty four hours following initiation of steroid DNA prep) and were amplified with a PCR program consisting of 3 min treatment, rabbits were anesthetized with xylazine and ketamine intraat 94°C, 35 cycles of 30 s at 94°C, 30 s at 55°C and 2 min at muscularly and inoculated intracisternally with 0.3 ml of yeast suspension 72°C, and a final step of 5 min at 72°C. Synthetic oligonucleotides through a 25 gauge needle on a 3 ml syringe. Three rabbits received corresponding to sequences in the CNA1 gene flanking the site of the wild-type strain H99, three rabbits the cna1Δ deletion mutant strain and ADE2 insertion served as primers, including 377 (5Ј-AAGCTTATGthree rabbits the cna1Δ mutant strain transformed with the wild-type ATGTTTGATCCG) and 566 (5Ј-CGAAGAGTGCACGGCTCATA), CNA1 gene (cna1Δ ϩ CNA1). Rabbits were sedated with ketamine and which yield PCR products of~2000 and~2500 bp for the CNA1 wildxylazine on days 2, 5, 7 and 12 after inoculation, and CSF was type and cna1Δ mutant alleles, respectively. Two types of homologous withdrawn. Quantitative yeast cultures were performed by plating serial integration events resulting in ts mutants were observed. In the first, the dilutions of CSF in PBS on YPD medium, incubating at 24°C for 72 h, chromosomal CNA1 gene had been replaced by the deletion allele by a and counting colony-forming units. double cross-over event. These isolates were inviable at 39°C and did not give rise to temperature-resistant revertants at this temperature. In the other type, both the deletion allele and a truncated wild-type gene
